What are the adverse reactions of pomalidomide?

Pomalidomide is a third-generation IMiD drug with immunomodulatory and anti-angiogenic activities. It is mainly used to treat multiple myeloma. It exerts anti-tumor effects by binding to the E3 ligase cereblon (CRBN), affecting gene expression, promoting apoptosis and cell cycle arrest. However, like other immunomodulators and chemotherapy drugs, pomalidomide may also cause a series of adverse reactions during treatment.

First, pomalidomide may cause adverse reactions in the blood system, such as thrombocytopenia, neutropenia, lymphopenia, and anemia. These blood system problems may lead to increased risks of bleeding, infection, and more. Therefore, patients need regular blood tests to monitor their blood cell counts while receiving pomalidomide.

Secondly, pomalidomide may also cause digestive system reactions, such as nausea, vomiting, diarrhea and indigestion. These gastrointestinal reactions may affect the patient's diet and daily life. Your doctor can recommend appropriate relief measures, such as dietary modifications or medication support.

In addition, pomalidomide may also cause adverse reactions in the respiratory system, such as dyspnea, cough, etc. At the same time, patients may also experience neurological problems, such as dizziness, confusion, etc., which may affect the patient's daily life and work.

Pomalidomide may also cause adverse reactions in the skin and ancillary tissues, such as rash, dry skin, itching, and night sweats. In rare cases, patients may develop severe skin reactions, such as Stevens-Johnson syndrome, toxic epidermal necrosis, etc., which may require permanent discontinuation of the drug.

Of note, pomalidomide may also increase a patient's risk of venous and arterial thromboembolic events, such as deep vein thrombosis, pulmonary embolism, myocardial infarction, and stroke. Therefore, in patients with known risk factors, steps should be taken to minimize all modifiable factors and to implement thromboprophylaxis.

In general, pomalidomide shows good efficacy in the treatment of multiple myeloma, but patients need to pay close attention and deal with possible adverse reactions during use. If you have any symptoms of discomfort, you should seek medical treatment promptly and inform your doctor.

xa0

Reference materials:https://www.mayoclinic.org/zh-hans/drugs-supplements/pomalidomide-oral-route/description/drg-20060888

xa0